Linshom Medical, Inc., a technology and life science startup based in Maryland, has closed a $650,000 Series A funding round with investments from the Abell Foundation and TEDCO. The company's mission is to revolutionize patient care by developing innovative solutions that alert medical professionals to breathing issues as soon as they arise, potentially saving lives. With a team of experienced professionals, Linshom Medical is poised to make a significant impact in the healthcare industry.
The company's primary offering is a device that monitors breathing patterns and alerts medical professionals in real-time, enabling them to respond quickly to any potential issues. This technology has the potential to revolutionize patient care, particularly in hospitals and healthcare facilities where patients are at a higher risk of respiratory complications.

Linshom Medical's funding will be used to further develop and refine their technology, as well as expand their reach into the healthcare market. The investment from the Abell Foundation and TEDCO is a testament to the company's potential and the growing demand for innovative healthcare solutions.